Cargando…

Progression of diabetic kidney disease: Who is at risk?

Detalles Bibliográficos
Autor principal:	Jamale, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819385/ https://www.ncbi.nlm.nih.gov/pubmed/33109780 http://dx.doi.org/10.4103/jpgm.JPGM_1014_20

Ejemplares similares

Glomerulonephritis registry: Need of the hour
por: Jamale, T
Publicado: (2022)

Beyond the Glomerulus—Kidney Tubule Markers and Diabetic Kidney Disease Progression
por: Bullen, Alexander L., et al.
Publicado: (2021)

Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial
por: Schechter, Meir, et al.
Publicado: (2020)

Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes
por: de Boer, Ian H., et al.
Publicado: (2018)

Who is at increased risk for acute kidney injury following noncardiac surgery?
por: Murray, Patrick
Publicado: (2009)

Dual therapy and diabetic kidney disease
por: Desai, T.
Publicado: (2015)

Impact of empagliflozin on diabetic kidney disease
por: Koya, Daisuke
Publicado: (2017)

Diabetic Kidney Disease: The “Silent” Majority?
por: Yau, Amy, et al.
Publicado: (2021)

A Paradigm to Discover Biomarkers Associated With Chronic Kidney Disease Progression
por: Ali, Ibrahim, et al.
Publicado: (2020)

Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease
por: Persson, Frederik, et al.
Publicado: (2019)

Strengthening evidence to inform health systems: opportunities for the WHO and partners to accelerate progress on non-communicable diseases
por: Hyder, Adnan A, et al.
Publicado: (2023)

Contribution of sex hormones in the progression of diabetic microvascular diseases
por: Jia, Weiping
Publicado: (2012)

Getting a Notch Closer to Understanding Diabetic Kidney Disease
por: Ahn, Seon-Ho, et al.
Publicado: (2010)

A Transcriptional Blueprint for Human and Murine Diabetic Kidney Disease
por: Bhalla, Vivek, et al.
Publicado: (2013)

Chronic Kidney Disease and Diabetes–A Potential Causal Link
por: Lai, Shenghan
Publicado: (2016)

Novel anti-inflammatory drugs for the treatment of diabetic kidney disease
por: Heerspink, Hiddo J. L., et al.
Publicado: (2016)

Determinants of the Risk of Diabetic Kidney Disease and Diabetic Retinopathy Independent of Glucose Exposure
por: Koo, Bo Kyung
Publicado: (2016)

COVID-19: A nephrologists' perspective
por: Jamale, TE, et al.
Publicado: (2022)

Patients with kidney failure who cannot access dialysis in rural and remote areas of Canada should be prioritized for kidney transplantation
por: Trachtenberg, Aaron J., et al.
Publicado: (2021)

New solutions to old problems—metabolic acidosis in chronic kidney disease
por: Sy, John, et al.
Publicado: (2020)

Veverimer for treatment of chronic metabolic acidosis in patients with chronic kidney disease
por: Gone, Anirudh R., et al.
Publicado: (2020)

Staying Connected: Transcriptomics in the Search for Novel Diabetic Kidney Disease Treatments
por: Terker, Andrew S., et al.
Publicado: (2021)

Peripheral Neuropathy in Children with Chronic Kidney Disease: Are we Looking Enough? An Editorial
por: Viswanathan, Shanthi
Publicado: (2022)

Hyperuricemia: A non-traditional risk factor for development and progression of chronic kidney disease?
por: Kang, Duk-Hee
Publicado: (2012)

Identifying high-risk stage IIIA cutaneous melanoma patients who might benefit from adjuvant therapy: the importance of micrometastatic tumor burden
por: Egger, Michael E.
Publicado: (2023)

Is There a Sweet Spot for Nrf2 Activation in the Treatment of Diabetic Kidney Disease?
por: Hall, Evan T., et al.
Publicado: (2014)

Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease
por: Drexler, Yelena, et al.
Publicado: (2023)

Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney disease
por: Gabbay, Ezra, et al.
Publicado: (2015)

Understanding the vulnerability of people with disabilities to HIV: Who is at risk?
por: Hanass-Hancock, Jill
Publicado: (2020)

Living with Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician Perspective
por: Nicholas, Susanne B., et al.
Publicado: (2022)

Biomarkers for early diagnosis of diabetic kidney disease: still a long way to go
por: Kumar, Vivek, et al.
Publicado: (2022)

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment
por: Scott, David
Publicado: (2013)

Optimal Early Diagnosis and Monitoring of Diabetic Kidney Disease in Type 2 Diabetes Mellitus: Addressing the Barriers to Albuminuria Testing
por: Christofides, Elena A., et al.
Publicado: (2021)

Among Those Who Hinder Progress
Publicado: (1900)

Back to the Future: Glomerular Hyperfiltration and the Diabetic Kidney
por: Tuttle, Katherine R.
Publicado: (2017)

Urinary adiponectin and progression of diabetic nephropathy in type 1 diabetes
por: Ha, Kyoung Hwa, et al.
Publicado: (2015)

Among patients with advanced ovarian carcinoma, who benefits from bevacizumab the most?
por: Babaier, Abdulaziz, et al.
Publicado: (2023)

New Landmarks to Slow the Progression of Chronic Kidney Disease
por: Simonini, Marco, et al.
Publicado: (2022)

Protective Effect of Nrf2 and Catalase in Maternal Diabetes-Induced Perinatal Hypertension and Kidney Disease
por: Vaziri, Nosratola D.
Publicado: (2012)

Addressing the Challenge of Potentially Hazardous Elements in the Reduction of Hypertension, Diabetes and Chronic Kidney Disease in the Caribbean
por: Fevrier-Paul, Adwalia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jm2po78pqs9qqb1sg8mevmc3mp